Seminars in Hematology
Volume 45, Issue 4 , Pages 261-266, October 2008

Anemia and the Frail Elderly

  • Andrew S. Artz

      Affiliations

    • Corresponding Author InformationAddress correspondence to Andrew Artz, MD, 5841 S Maryland Ave, MC 2115, Chicago, IL 60637

University of Chicago Pritzker School of Medicine, Section of Hematology/Oncology, Chicago, IL

Frailty engenders a recognizable clinical syndrome of vulnerability to stressors related to impaired physiologic reserve that primarily occurs among older adults. Features of frailty include weight loss, exhaustion, muscle weakness, performance impairment, and cognitive slowing and can be identified independent of comorbid conditions. Among frail older adults, anemia prevalence is markedly increased. The interaction between anemia and frailty is complex and confidently separating cause and effect may not be possible. Nevertheless, anemia functions as a powerful prognostic factor for the development of frailty related problems such as muscle weakness, reduced performance, falls, and mortality. Further, mildly reduced hemoglobin shows a similar association with adverse outcomes. The data strongly intimate that anemia predisposes or accelerates the development of frailty. Anemia interventional studies are sorely needed to determine whether treatment may mitigate either the development of frailty and/or the sequela of frailty.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Research support from Amgen (Thousand Oaks, CA).

PII: S0037-1963(08)00104-2

doi:10.1053/j.seminhematol.2008.06.002

Seminars in Hematology
Volume 45, Issue 4 , Pages 261-266, October 2008